DOI: https://doi.org/10.30841/2307-5090.1 (56).2016.95428

Проблемы идиопатического мужского бесплодия

І. І. Горпинченко, В. С. Савченко, К. Р. Нуріманов, Т. В. Порошина, Г. М. Драннік

Аннотация


В статье представлен анализ эффективности методов лечения мужского идиопатического бесплодия.

Цель исследования: оценить связь показателей спермограммы, цитокинов ТНФ-α и ТФР-β1, антиоксидантных свойств эякулята при мужском идиопатическом бесплодии, а также динамики состояния фертильности под влиянием антиоксидантных средств.

Материалы и методы. В исследование были включены 32 пациента с идиопатическим бесплодием в возрасте 18–45 лет. Изучали динамику показателей спермы (в том числе ее антиоксидантных свойств – НСТ-тест) и цитокинов эякулята (ТНФ-α, ТФР-β1) под влиянием приема препарата Новофертил в течение 6 мес (по 1 капсуле 2 раза в день).

Результаты. Наблюдали статистически значимое (р<0,05) увеличение подвижности сперматозоидов и количество живых сперматозоидов, связь между показателями НСТ-теста и подвижностью сперматозоидов, НСТ-теста и количеством живых сперматозоидов. Иммунологические отклонения в динамике не изменились.

Заключение. Антиоксидантные средства подтвердили эффективность при мужском идиопатическом бесплодии.


Ключевые слова


идиопатическое бесплодие; антиоксиданты; цитокины; лечение

Полный текст:

PDF

Литература


de Kretser D.M. Male infertility // Lancet. – 1997. – № 349. – P. 787–790.

Wang C., Swerdloff R.S. Limitations of semen analysis as a test of male fertility and anticipated needs from newer tests // Fertility and Sterility. – 2014. – № 102. – P. 1502–1507.

Leifke E., Nieschlag E. Male infertility treatment in the light of evidence-based medicine // Andrologia. – 1996. – № 28 (Suppl 1). – P. 23–30.

Jung J.H., Seo J.T. Empirical medical therapy in idiopathic male infertility: promise or panacea? // Clinical and Experimental Reproductive Medicine. – 2014. – № 41. – P. 108–114

Rittenberg V., El-Toukhy T. Medical treatment of male infertility // Human Fertility. – 2010. – № 13. – P. 208–216.

Aston K.I. Genetic susceptibility to male infertility: news from genome-wide association studies // Andrology. – 2014. – № 2 (3). – P. 315–321.

de Lamirande E., Harakat A., Gagnon C., Human sperm capacitation induced by biological fluids and progesterone, but not by NADH or NADPH, is associated with the production of superoxide anion //Andrology. – 1998. – № 19 (2). – P. 215–225.

Wang X., Sharma R.K., Sikka S.C. et al. Oxidative stress is associated with increased apoptosis leading to spermatozoa DNA damage in patients with male factor infertility // Fertil. Steril. – 2003. – № 80 (3). – P. 531–535.

Mazzilli F., Rossi T., Marchesini M., Ronconi C., Dondero F. Superoxide anion in human semen related to seminal parameters and clinical aspects // Fertil. Steril. – 1994. – № 62 (4). – P. 862–868.

Sharma R.K., Pasqualotto F.F., Nelson D.R., Thomas A.J.Jr., Agarwal A. The reactive oxygen species-total antioxidant capacity score is a new measure of oxidative stress to predict male infertility // Hum. Reprod. – 1999. – № 14 (11). – P. 2801–2807.

Zalata A., Hafez T., Mahmoud A., Comhaire F. Relationship between resazurin reduction test, reactive oxygen species generation, and gamma-glutamyltransferase // Hum. Reprod. – 1995. – № 10 (5). – P. 1136–1140.

Pahune P.P., Choudhari A.R., Muley P.A. The total antioxidant power of semen and its correlation with the fertility potential of human male subjects // Journal of Clinical and Diagnostic Research. – 2013. – № 6 (7). – P. 991–995.

Greco E., Iacobelli M., Rienzi L., Ubaldi F., Ferrero S., Tesarik J. Reduction of the incidence of sperm DNA fragmentation by oral antioxidant treatment // Journal of Andrology. – 2005. – № 3 (26). – P. 349–353.

Safarinejad M.R. The effect of coenzyme Q10 supplementation on partner pregnancy rate in infertile men with idiopathic oligoasthenoteratozoospermia: an open-label prospective study // International Urology and Nephrology. – 2012. – № 3 (44). – P. 689–700.

Gupta N.P., Kumar R. Lycopene therapy in idiopathic male infertility – a preliminary report // International Urology and Nephrology. – 2002. – № 3 (34). – P. 369–372.

Chen X.F., Li Z., Ping P., Dai J.C., Zhang F.B., Shang X.J. Efficacy of natural vitamin E on oligospermia and asthenospermia: a prospectivemulti-centered randomized controlled study of 106 cases // Zhonghua Nan Ke Xue. – 2012. – № 5 (18). – P. 428–431.

Wang Y.X., Yang S.W., Qu C.B. et al. L-carnitine: safe and effective for asthenozoospermia // Zhonghua Nan Ke Xue. – 2010. – № 5 (16). – P. 420–422.

Moslemi M.K., Tavanbakhsh S. Seleniumvitamin E supplementation in infertile men: effects on semen parameters and pregnancy rate // International Journal of General Medicine. – 2011. – № 4. – P. 99–104.

Cavallini G., Magli M.C., Crippa A., Ferraretti A.P., Gianaroli L. Reduction in sperm aneuploidy levels in severe oligoasthenoteratospermic patients after medical therapy: a preliminary report. // Asian Journal of Andrology. – 2012. – № 4 (14). – P. 591–598.

Greco E., Romano S., Iacobelli M. et al. ICSI in cases of sperm DNA damage: beneficial effect of oral antioxidant treatment // Human Reproduction. – 2005. – № 9 (20). – P. 2590–2594.

Safarinejad M.R. Efficacy of coenzyme Q10 on semen parameters, sperm function and reproductive hormones in infertile men // Journal of Urology. – 2009. – № 1 (182), pp. 237–248.

Safarinejad M.R., Safarinejad S., Shafiei N., Safarinejad S. Effects of the reduced form of coenzyme Q10 (ubiquinol) on semen parameters in men with idiopathic infertility: a doubleblind, placebo controlled, randomized study // Journal of Urology. – 2012. – № 2 (188). – P. 526–531.

Piomboni P., Gambera L., Serafini F., Campanella G., Morgante G., de Leo V. Sperm quality improvement after natural anti-oxidant treatment of asthenoteratospermic men with leukocytospermia // Asian Journal of Andrology. – 2008. – № 2 (10). – P. 201–206.

Balercia G., Mosca F., Mantero F. et al. Coenzyme Q10 supplementation in infertile men with idiopathic asthenozoospermia: an open, uncontrolled pilot study // Fertility and Sterility. – 2004. – № 1 (81). – P. 93–98.

Akmal M., Qadri J.Q., Al-Waili N.S., Thangal S., Haq A., Saloom K.Y. Improvement in human semen quality after oral supplementation of vitamin C // Journal of Medicinal Food. – 2006. – № 3 (9). – P. 440–442.

Santi D., Granata A.R.M., Simoni M. FSH treatment of male idiopathic infertility improves pregnancy rate: a meta-analysis // Endocrine Connections. – 2015. – № 4. – P. 46–58.

Blumenfeld Z., Frisch L., Conn P.M. Gonadotropin-releasing hormone (GnRH) antibodies formation in hypogonadotropic azoospermic men treated with pulsatile GnRHdiagnosis and possible alternative treatment // Fertil. Steril. – 1988. – № 50. – P. 622–629.

Gordetsky J., van Wijngaarden E., O’Brien J. Redefining abnormal follicle-stimulating hormone in the male infertility population // BJU Int. – 2012. – № 110. – P. 568–752.

Clark R.V., Sherins R.J. Treatment of men with idiopathic oligozoospermic infertility using the aromatase inhibitor, testolactone. Results of a double-blinded, randomized, placebo-controlled trial with crossover // J. Androl. – 1989. – № 10. – 240–247.

Pavlovich C.P., King P., Goldstein M. et al. Evidence of a treatable endocrinopathy in infertile men // J. Urol. – 2001. – № 165. – P. 837–841.

Chua M.E., Escusa K.G., Luna S. et al. Revisiting oestrogen antagonists (clomiphene or tamoxifen) as medical empiric therapy for idiopathic male infertility: a meta-analysis // Andrology. – 2013. №1. – P.749-757.

Vandekerckhove P., Lilford R., Vail A. et al. Clomiphene or tamoxifen for idiopathic oligo/asthenospermia // Cochrane Database Syst. Rev. 2000 (2):CD000151.

Willets A.E., Corbo J.M., Brown J.N. Clomiphene for the treatment of male infertility // Reprod. Sci. – 2013. – № 20. – P. 739–744.

Drannik G.M., Gorpinchenko I.I., Poroshina T.V., Nurimanov K.R., Savchenko V.S., Dobrovol'ska L.I. Tarasova I.I. Efekti citokiniv ejakuljatu na pokazniki patospermii' u hvorih na hronichnij abakterial'nij prostatit, uskladnenij ekskretorno-toksichnim nepliddjam // Zdorov'e muzhchiny. – 2013. – № 3 (43). – S. 181–184.

Nurimanov K.R. Vpliv lejkocitiv ta ginterferonu spermi na pokazniki fertil'nosti u hvorih na hronichnij abakterial'nij prostatit // Zdorov'e muzhchiny. – 2015. – № 4 (55). – S. 82–84.

Havrylyuk A., Chopyak V., Boyko Y, Kril I., Kurpisz M. Cytokines in the blood and semen of infertile patients // Cent. Eur. J. Immunol. – 2015. – № 40 (3). – P. 337–44.

Gorpinchenko I.I. Metabolicheskaja terapija v kompleksnom lechenii jekskretornotoksicheskogo besplodija. Opyt primenenija preparata gammafertil // Zdorov'e muzhchiny. – 2015. – № 3 (54). – S. 36–41.

World Health Organization, WHO Laboratory Manual for the Examination and Processing of Human Semen, WHO Press, Geneva, Switzerland, 5th edition, 2010.




Copyright (c) 2016 Здоровье мужчины

Creative Commons License
Эта работа лицензирована Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

ISSN 2412-5547 (Online), ISSN 2307-5090 (Print)